• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    US Home Infusion Therapy Devices Market

    ID: MRFR/Pharma/18122-HCR
    100 Pages
    Garvit Vyas
    September 2025

    US Home Infusion Therapy Devices Market Research Report By Device Type (Infusion Pumps, Syringe Pumps, Ambulatory Pumps, Enteral Feeding Pumps), By Therapy Type (Antibiotic Therapy, Chemotherapy, Nutrition Therapy, Pain Management), By End User (Hospitals, Home Care Settings, Nursing Homes) and By Components (Infusion Set, Catheters, Accessories, Software Solutions) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Home Infusion Therapy Devices Market Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    US Home Infusion Therapy Devices Market Summary

    The US Home Infusion Therapy Devices market is projected to grow from 5 USD Billion in 2024 to 10.5 USD Billion by 2035.

    Key Market Trends & Highlights

    US Home Infusion Therapy Devices Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate of 6.98 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 10.5 USD Billion, indicating robust growth potential.
    • In 2024, the market is valued at 5 USD Billion, reflecting a strong foundation for future expansion.
    • Growing adoption of home healthcare solutions due to an increasing preference for outpatient care is a major market driver.

    Market Size & Forecast

    2024 Market Size 5 (USD Billion)
    2035 Market Size 10.5 (USD Billion)
    CAGR (2025-2035) 6.98%

    Major Players

    Parker Hannifin, C.R. Bard, Hospira, Smiths Medical, CareFusion, Terumo Corporation, Medtronic, Baxter International, Fresenius Kabi, B. Braun Melsungen, Amgen, ICU Medical, Halyard Health, Becton Dickinson, Alpha Vantage

    US Home Infusion Therapy Devices Market Trends

    The US Home Infusion Therapy Devices Market is witnessing significant growth, driven by an increasing preference for home healthcare solutions. Factors such as the rising aging population, chronic diseases, and a shift towards outpatient care are fueling this trend. Additionally, advancements in technology are enhancing the safety and efficacy of infusion therapy, making it more appealing for both healthcare providers and patients.

    Healthcare reforms that emphasize cost-effective treatments further drive the adoption of home infusion therapies, as they reduce hospital stays and associated costs. Opportunities within this market are abound, particularly in developing advanced infusion devices and integrated delivery systems. The emphasis on personalized medicine is opening avenues for companies to create tailored infusion solutions, catering to specific patient needs. Moreover, home healthcare providers can expand their offerings through partnerships with technology firms to incorporate telehealth solutions, thus increasing patient engagement and monitoring efficiency.

    In recent times, the US market has also seen a rise in demand for infusion devices that are user-friendly, portable, and equipped with smart technology for remote monitoring. The ongoing developments related to telemedicine and home healthcare services have reshaped how patients receive treatment, further stimulating interest in home infusion therapy. Regulatory policies supporting patient care at home and the push to reduce hospital readmissions are reinforcing this trend. As more patients opt for home-based therapies due to comfort and convenience, the market will likely continue expanding to meet these evolving needs.

    Market Segment Insights

    Home Infusion Therapy Devices Market Device Type Insights

    The Device Type segment within the US Home Infusion Therapy Devices Market plays a pivotal role in shaping the overall landscape of the industry, which is experiencing substantial growth driven by technological advancements and increasing patient demand for at-home care solutions. Infusion Pumps are essential devices used for delivering medications and nutrients efficiently, providing precision and control that are crucial for patient treatment outcomes. Syringe Pumps offer versatility, often preferred for administering smaller volumes of fluids, and are widely utilized in cases where accuracy is paramount.

    Ambulatory Pumps facilitate patient mobility by allowing individuals to receive therapy on the go, thereby enhancing comfort and independence while managing chronic conditions. Enteral Feeding Pumps are specialized devices aimed at patients requiring nutritional support, ensuring that timely and adequate food intake is maintained even outside of traditional clinical settings. The integration of these devices is essential for addressing the growing patient population seeking home healthcare services, driven by the rising prevalence of chronic diseases and a significant shift towards personalized medicine.

    Furthermore, home-based infusion therapy not only curtails hospital stays, thereby reducing healthcare costs, but also empowers patients to partake in their treatment journey from the comfort of their homes. Market dynamics reveal a notable trend toward the incorporation of smart technology in these devices, allowing for enhanced monitoring and user-friendly interfaces that improve patient safety and adherence to therapy protocols.

    Given these factors, the Device Type segment is projected to continue to evolve, paving the way for innovative solutions that cater to diverse treatment needs and setting a foundation for robust future growth within the US Home Infusion Therapy Devices Market.

    As patient preferences shift towards home treatment options, the significance of these devices in healthcare delivery is anticipated to expand, supported by a favorable regulatory framework and an increasing focus on value-based care initiatives. The collective momentum of these factors positions the Device Type segment as a key driver in transforming home infusion therapy into a more practical and effective option for a wide range of patients.

    Home Infusion Therapy Devices Market Therapy Type Insights

    The US Home Infusion Therapy Devices Market has shown significant growth attributed to the increasing demand across various Therapy Types such as Antibiotic Therapy, Chemotherapy, Nutrition Therapy, and Pain Management. Antibiotic Therapy is particularly critical for managing infections and is gaining traction due to the rising prevalence of chronic infections and the aging population in the US. Chemotherapy remains essential for cancer management, with patients preferring home-based therapies for convenience and comfort. Nutrition Therapy, especially for patients with malnutrition or specific dietary needs, is experiencing increased adoption, thereby improving patient quality of life.

    Additionally, Pain Management therapy is vital for patients suffering from chronic pain conditions, offering a significant alternative to traditional pain relief methods. This diversity in therapy types underscores the US Home Infusion Therapy Devices Market segmentation, revealing distinct needs and growth potentials. The growing trend towards home-based healthcare solutions, catalyzed by advancements in technology, challenges for healthcare access, and evolving patient preferences, supports the expansion of all these therapy types in the market. Each segment presents unique opportunities, particularly in enhancing patient compliance and management through tailored home infusion solutions.

    Home Infusion Therapy Devices Market End User Insights

    The End User segment of the US Home Infusion Therapy Devices Market plays a vital role in shaping the overall dynamics of this industry. Hospitals serve as a critical hub for the administration of these devices, supporting complex cases that require specialized care. With an increasing focus on patient-centered care, Home Care Settings are gaining significant traction, allowing patients to receive treatment in the comfort of their homes, thereby improving recovery experiences and overall satisfaction.

    Nursing Homes, on the other hand, are essential for managing chronic conditions among elderly populations, forming a crucial part of the healthcare continuum in the US.

    This growing trend can be attributed to the US government's emphasis on reducing hospital stays, resulting in an increased demand for effective home-based therapies. The segmentation of the US Home Infusion Therapy Devices Market illustrates the diverse needs of various patient populations, highlighting the opportunities for tailored solutions that enhance patient outcomes and operational efficiency across these different settings. Moreover, the aging population and rising prevalence of chronic diseases are expected to drive growth within these specific user segments, making them increasingly important in addressing contemporary healthcare challenges.

    Home Infusion Therapy Devices Market Components Insights

    The Components segment of the US Home Infusion Therapy Devices Market plays a crucial role in enhancing the efficiency and safety of home-based treatment protocols. This segment includes essential elements such as Infusion Sets, Catheters, Accessories, and Software Solutions, each being vital for patient care and treatment management. Infusion Sets are instrumental in delivering medications directly into the bloodstream, ensuring precise dosing and minimizing complications. Catheters facilitate easy access to veins while reducing the risk of infections, thus making them indispensable for patients requiring long-term therapy.

    Meanwhile, Accessories are essential for maintaining the integrity and functionality of infusion systems. Software Solutions are increasingly important as they support healthcare professionals in monitoring treatment progress and managing patient data more efficiently. This market is witnessing steady growth, driven by factors such as the increasing prevalence of chronic diseases in the US and the growing preference for home healthcare services. With technological advancements and a rising aging population, the Components segment is poised to become increasingly significant in the overall landscape of home infusion therapy.

    Get more detailed insights about US Home Infusion Therapy Devices Market

    Key Players and Competitive Insights

    The US Home Infusion Therapy Devices Market has been experiencing considerable growth, driven by an increasing number of patients opting for home-based treatment solutions. This shift is attributed to various factors, including the rising preference for home healthcare services, technological advancements in infusion delivery systems, and the cost-effective nature of home therapies as compared to hospital stays. The landscape is marked by a mix of established players who have significant market share and new entrants looking to capitalize on the growing demand for personalized care solutions.

    As competition intensifies, companies are focusing on innovation, product differentiation, and strategic partnerships to enhance their market position, ensuring they meet evolving patient needs and regulatory requirements.

    Parker Hannifin

    Parker Hannifin has emerged as a strong player within the US Home Infusion Therapy Devices Market, recognized for its commitment to quality and innovation. The company's strengths lie in its advanced fluid control systems, which provide reliable and accurate infusion therapies for patients in home settings. Parker Hannifin has built a reputation for delivering cutting-edge technology and solutions designed to enhance patient outcomes and streamline healthcare provider workflows. Additionally, its robust distribution network and strong customer support contribute to its market presence, allowing for effective reach within the highly competitive home infusion segment.

    The company continues to invest in research and development, ensuring that its product offerings remain at the forefront of therapy advancements, thus reinforcing its competitive advantage in the market.

    C.R. Bard

    C.R. Bard plays a significant role in the US Home Infusion Therapy Devices Market, focusing on providing a wide range of products designed specifically for infusion therapy. With a robust portfolio that includes catheters, infusion sets, and related accessories, C.R. Bard is well-positioned to meet the demands of healthcare professionals and patients alike. The company has established a strong market presence, characterized by its focus on quality, safety, and innovation. C.R. Bard is recognized for its strategic mergers and acquisitions, which have bolstered its capabilities and expanded its product offerings within the home infusion space.

    Its commitment to research and development fosters ongoing product innovation, pushing the boundaries of infusion technology. These strengths enable C.R. Bard to maintain a competitive edge and ensure it remains a trusted supplier within the home healthcare sector in the United States.

    Key Companies in the US Home Infusion Therapy Devices Market market include

    Industry Developments

    The US Home Infusion Therapy Devices Market has recently been influenced by significant developments, including advancements in technology and an increasing shift towards home healthcare. Companies such as Baxter International and Medtronic are focusing on innovative infusion devices designed to enhance patient safety and comfort. In October 2023, C.R. Bard announced a strategic partnership aimed at expanding their product range in the home infusion sector. Growth in market valuation for firms like Fresenius Kabi and B.

    Braun Melsungen is also notable, with recent projections indicating a surge in demand for at-home healthcare solutions driven by the aging population and preference for at-home treatments.

    The COVID-19 pandemic catalyzed changes in healthcare delivery, intensifying interest in home infusion therapies. In terms of mergers and acquisitions, Smiths Medical completed the acquisition of CareFusion in September 2022 to strengthen its portfolio in the home infusion segment. Furthermore, in July 2022, ICU Medical acquired the assets of Halyard Health, further consolidating its position in the market. Overall, the landscape of the US Home Infusion Therapy Devices Market continues to evolve, supported by a focus on innovation and partnerships.

    Market Segmentation

    Home Infusion Therapy Devices Market End User Outlook

    • Hospitals
    • Home Care Settings
    • Nursing Homes

    Home Infusion Therapy Devices Market Components Outlook

    • Infusion Set
    • Catheters
    • Accessories
    • Software Solutions

    Home Infusion Therapy Devices Market Device Type Outlook

    • Infusion Pumps
    • Syringe Pumps
    • Ambulatory Pumps
    • Enteral Feeding Pumps

    Home Infusion Therapy Devices Market Therapy Type Outlook

    • Antibiotic Therapy
    • Chemotherapy
    • Nutrition Therapy
    • Pain Management

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 4.62(USD Billion)
    MARKET SIZE 2024 5.0(USD Billion)
    MARKET SIZE 2035 10.5(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 6.978% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Billion
    KEY COMPANIES PROFILED Parker Hannifin, C.R. Bard, Hospira, Smiths Medical, CareFusion, Terumo Corporation, Medtronic, Baxter International, Fresenius Kabi, B. Braun Melsungen, Amgen, ICU Medical, Halyard Health, Becton Dickinson, Alpha Vantage
    SEGMENTS COVERED Device Type, Therapy Type, End User, Components
    KEY MARKET OPPORTUNITIES Aging population demand, Chronic disease management growth, Increasing preference for home care, Advancements in infusion technology, Cost-effective treatment solutions
    KEY MARKET DYNAMICS Aging population, Rising chronic diseases, Increasing home healthcare adoption, Technological advancements, Cost-effective treatment options
    COUNTRIES COVERED US

    FAQs

    What is the projected market size of the US Home Infusion Therapy Devices Market in 2024?

    The US Home Infusion Therapy Devices Market is expected to be valued at 5.0 USD Billion in 2024.

    What is the expected market value of the US Home Infusion Therapy Devices Market by 2035?

    By 2035, the US Home Infusion Therapy Devices Market is anticipated to reach a value of 10.5 USD Billion.

    What is the expected CAGR for the US Home Infusion Therapy Devices Market from 2025 to 2035?

    The market is projected to grow with a compound annual growth rate of 6.978% from 2025 to 2035.

    Which device segment in the US Home Infusion Therapy Devices Market is expected to be the largest in 2024?

    In 2024, the Infusion Pumps segment is expected to be the largest, valued at 2.0 USD Billion.

    What will be the market value for Syringe Pumps in 2035?

    The market value for Syringe Pumps is expected to reach 3.2 USD Billion by 2035.

    Who are the major players in the US Home Infusion Therapy Devices Market?

    Key players include Parker Hannifin, C.R. Bard, Hospira, Smiths Medical, and Baxter International.

    What is the projected market size for Enteral Feeding Pumps in 2024?

    The market size for Enteral Feeding Pumps is expected to be valued at 0.7 USD Billion in 2024.

    What is the expected value for Ambulatory Pumps in the market by 2035?

    By 2035, Ambulatory Pumps are projected to have a market value of 1.8 USD Billion.

    What are some emerging trends in the US Home Infusion Therapy Devices Market?

    Emerging trends include advancements in device technology and increasing demand for home-based healthcare solutions.

    What challenges does the US Home Infusion Therapy Devices Market face?

    Challenges include regulatory compliance and the need for continuous technological innovations.

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Stories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials